Christian Hansen

Keine laufenden Positionen mehr

60 Jahre

Health Technology

Consumer Services

Commercial Services

Profil

Christian Hansen is co-founder and partner of Nordic Biotech.
Dr. Hansen has a background as a biotech entrepreneur, biotech intellectual property rights expert and business development executive, combined with a scientific career.
He has been actively involved in biotech investment since the late 1990’s.
From 2000 to 2001 Dr. Hansen was President of Maxygen's Protein Pharma Division, and Managing Director of its Danish subsidiary Maxygen ApS, employing about 75 people.
From 1999 to 2000, Dr. Hansen was CEO and founder of ProFound Pharma A/S, a Danish start-up company focused on developing 2nd generation protein pharmaceuticals.
From 1992 to 1999, Dr. Hansen held executive positions at Novo Nordisk A/S, including as Director of Intellectual Property Strategy, which is one of his core areas of expertise.
In this capacity, Dr. Hansen was responsible for numerous patent, license and collaborative agreement strategies and negotiations, and was a member of Research Management.
Dr. Hansen holds an MSc (1989) in chemical engineering, a PhD (1992) in molecular biology/biochemistry and an MBA.

Ehemalige bekannte Positionen von Christian Hansen

Unternehmen	Position	Ende
Blue Note Pharmaceuticals BV Blue Note Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research services	Direktor/Vorstandsmitglied	04.02.2014
Nordic Biotech Advisors ApS Nordic Biotech Advisors ApS Investment ManagersFinance NB Capital is an active manager which provides financing for pre-seed, seed, later, and growth-stage capital requirements, and invests in both public and private companies. The firm invests in young and established companies operating in the health technology sector, and industries such as biotechnology and pharmaceuticals. NB Capital invests in companies located in Denmark, Northern Europe, and North America, and looks to take minority stake positions in its investments, as well as a seat on the board.	Private Equity Investor	31.12.2013
Rose Pharma A/S Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome	Direktor/Vorstandsmitglied	27.06.2012
Aditech Pharma AB Aditech Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Präsident	13.04.2010
OSTEOLOGIX HOLDINGS PLC	Direktor/Vorstandsmitglied	29.12.2009

Sehen Sie sich die Erfahrung von Christian Hansen im Detail an

Ausbildung von Christian Hansen

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Christian Hansen im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	13
Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology	Commercial Services
Novo Nordisk A/S Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care	Health Technology
Osteologix, Inc. /Old/ Osteologix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products	Health Technology
Profound Pharma AS Profound Pharma AS Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products	Health Technology
The University of Edinburgh The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Technical University of Denmark Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nordic Biotech Advisors ApS Nordic Biotech Advisors ApS Investment ManagersFinance NB Capital is an active manager which provides financing for pre-seed, seed, later, and growth-stage capital requirements, and invests in both public and private companies. The firm invests in young and established companies operating in the health technology sector, and industries such as biotechnology and pharmaceuticals. NB Capital invests in companies located in Denmark, Northern Europe, and North America, and looks to take minority stake positions in its investments, as well as a seat on the board.	Finance
Rose Pharma A/S Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome	Health Technology
Osteologix Holdings Plc Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Operates as an investment holding company with interest in development of pharmaceuticals	Health Technology
University of Strasbourg University of Strasbourg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Forward Pharma A/S Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications	Health Technology
Blue Note Pharmaceuticals BV Blue Note Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research services	Health Technology
Aditech Pharma AB Aditech Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology